Skip to main content

Table 5 EQ-5D-3L scores in the FMT and placebo groups

From: Randomized, double-blinded, placebo-controlled pilot study: efficacy of faecal microbiota transplantation on chronic fatigue syndrome

 

Mobility

Self-care

Usual activities

Pain/discomfort

Anxiety/depression

FMT group

 Patient 1

1 1 1

1 1 1

2 2 2

2 1 2

1 1 1

 Patient 2

2 2 2

2 2 2

3 3 3

2 1 2

1 1 1

 Patient 3

3–3

2–2

3–3

3–3

2–1

 Patient 4

2 2 2

2 2 2

3 3 3

2 2 1

1 1 1

 Patient 5

2 2 2

1 1 1

3 2 3

2 2 2

1 1 1

Placebo group

 Patient 6

2 2 2

2 2 2

2 2 2

3 2 3

2 2 2

 Patient 7

1 1 1

1 1 1

2 2 2

2 2 2

1 1 1

 Patient 8

2 2 1

2 1 1

3 3 2

3 3 2

2 2 2

 Patient 9

2 2 2

2 2 1

2 3 2

2 2 3

1 1 1

 Patient 10

2 2 2

1 1 1

2 3 2

2 2 3

2 2 2

 Patient 11

3 3 3

2 1 1

3 3 3

2 3 2

1 2 2

  1. EQ-5D-3L profiles in individual patients. In each dimension, the first digit represents the severity of symptoms at baseline, the second and the third digits describe severity at 1 month and at 6 months after the FMT, respectively. 1 = no problems; 2 = some problems; 3 = extreme problems/unable. 1 month data of patient 3 missing
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us